Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$8.88
+2.96%
Mkt Cap $781.96M
Analyst Ratings
Buy
2
Hold
4
Sell
2
Price Target (15 analysts)
$14.00
Range $14.00 – $14.00
Implied Upside
+57.7%
Consensus $14.00 vs current $8.88
NASDAQ·Healthcare·Biotechnology
$8.88
+2.96%
Mkt Cap $781.96M
Buy
2
Hold
4
Sell
2
Price Target (15 analysts)
$14.00
Range $14.00 – $14.00
+57.7%
Consensus $14.00 vs current $8.88